Results 11 to 20 of about 32,848 (294)

Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer [PDF]

Obstetrics & Gynecology Science, 2021
Objective To investigate the therapeutic efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) as consolidation treatment after completing first-line treatment in patients with advanced ovarian cancer.
Jieun Ko, Hyeong In Ha, Min Chul Choi, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Joon Mo Lee   +8 more
doaj   +1 more source

Current Situation of Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinoma

Zhongliu Fangzhi Yanjiu, 2021
Peritoneal carcinoma is a kind of malignant tumor which occurs and develops on the peritoneum, including primary and secondary tumors. Hyperthermic intraperitoneal chemotherapy is a combined therapy of intraperitoneal perfusion, hyperthermia and ...
ZHAN Hongjie, LIANG Han
doaj   +1 more source

Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial

Journal of Clinical Oncology, 2023
PURPOSE In patients with peritoneal metastasis (PM) from gastric cancer (GC), chemotherapy is the treatment of choice. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are still being debated. This randomized, controlled,
B. Rau, Hauke Lang, Alfred Koenigsrainer, Ines Gockel, H. Rau, Hendrik Seeliger, Christian Lerchenmueller, D. Reim, Roger Wahba, Martin Angele, S. Heeg, Tobias Keck, Arved Weimann, Stefan Topp, P. Piso, A. Brandl, Silke Schuele, Peter Jo, J. Pratschke, Sandra Wegel, A. Rehders, N. Moosmann, J. Gaedcke, Volker Heinemann, E. Trips, Markus Loeffler, P. Schlag, P. Thuss-Patience   +27 more
semanticscholar   +1 more source

Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer: A Phase 3 Randomized Clinical Trial.

JAMA Surgery, 2023
Importance Peritoneal metastasis in patients with locally advanced colon cancer (T4 stage) is estimated to recur at a rate of approximately 25% at 3 years from surgical resection and is associated with poor prognosis.
Á. Arjona-Sánchez, E. Espinosa-Redondo, A. Gutiérrez-Calvo, J. Segura-Sampedro, E. Pérez-Viejo, Vanessa Concepción-Martín, S. Sánchez-García, A. García-Fadrique, I. Prieto-Nieto, P. Barrios-Sánchez, J. Torres‐Melero, M. Ramirez Faraco, A. Prada-Villaverde, J. Carrasco-Campos, M. Artiles-Armas, P. Villarejo-Campos, G. Ortega-Pérez, Emrique Boldo-Roda, J. Sánchez-Hidalgo, Á. Casado-Adam, L. Rodriguez-Ortiz, E. Aranda, M. Cano-Osuna, César Díaz-López, A. Romero-Ruiz, J. Briceño-Delgado, S. Rufián-Peña   +26 more
semanticscholar   +1 more source

Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer

JAMA Surgery, 2022
Key Points Question Does hyperthermic intraperitoneal chemotherapy (HIPEC) after primary or interval cytoreductive surgery increase survival in patients with ovarian cancer?
M. Lim, Suk-Joon Chang, Boram Park, H. Yoo, C. Yoo, B. Nam, Sang-Yoon Park   +6 more
semanticscholar   +1 more source

Metal-enriched HSP90 nanoinhibitor overcomes heat resistance in hyperthermic intraperitoneal chemotherapy used for peritoneal metastases

Molecular Cancer, 2023
Clinical hyperthermic intraperitoneal chemotherapy (HIPEC) is regarded as a potential treatment that can prolong survival of patients with peritoneal metastases after cytoreductive surgery.
Qiang-Wei Wang, Peng Liu, Yingfei Wen, Kuan Li, Bo Bi, Binbin Li, Miaojuan Qiu, Shiqiang Zhang, You Li, Jia Li, Hengxing Chen, Yuan Yin, Leli Zeng, Changhua Zhang, Yulong He, Jing Zhao   +15 more
semanticscholar   +1 more source

Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy.

JAMA Surgery, 2023
Importance Hyperthermic intraperitoneal chemotherapy (HIPEC) followed by interval cytoreductive surgery (ICS) has shown survival benefits for patients with advanced-stage ovarian cancer.
Jung-yun Lee, Y. Lee, J. Son, Sunghoon Kim, Min Chul Choi, D. Suh, J. Song, Dae Gy Hong, Mi Kyung Kim, Jae-Hoon Kim, Suk-Joon Chang   +10 more
semanticscholar   +1 more source

Sodium thiosulfate during cisplatin-based hyperthermic intraperitoneal chemotherapy is associated with transient hypernatraemia without clinical sequelae

Pleura and Peritoneum, 2022
Cisplatin is commonly used during intraperitoneal chemotherapy however has well-established nephrotoxic side-effects. Sodium thiosulfate is often added to cisplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) protocols to mitigate this ...
Alonso Anais, Liauw Winston, Kennedy Helen, Alzahrani Nayef A., Morris David L.   +4 more
doaj   +1 more source

Anesthetic management of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A case report

Saudi Journal of Anaesthesia, 2023
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can significantly influence overall and disease-free survival in selected patients suffering from peritoneal surface malignancies (PSMs).
Nilanjana Howbora, Swaraj J Sonowal, Tridip J Borah, Sonai D Kakati, Anupam Das, Marie Ninu, Dokne Chintey   +6 more
doaj   +1 more source

Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial

Journal of Clinical Oncology, 2023
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available.
E. S. Zwanenburg, Charlotte El Klaver, D. D. Wisselink, Cornelis J. A. Punt, P. Snaebjornsson, J. Crezee, A. Aalbers, A. Brandt-Kerkhof, André J A Bremers, P. C. Burger, H. F. Fabry, F. Ferenschild, S. Festen, W. V. van Grevenstein, P. Hemmer, I. D. de Hingh, Niels F. M. Kok, M. Kusters, G. Musters, L. Schoonderwoerd, J. Tuynman, A. V. D. van de Ven, H. V. van Westreenen, M. J. Wiezer, D. Zimmerman, A. V. van Zweeden, M. G. Dijkgraaf, P. Tanis, C. Andeweg, V. Bastiaenen, W. Bemelman, J. V. D. van der Bilt, Johanne G Bloemen, F. D. den Boer, D. Boerma, D. T. Huinink, W. Brokelman, H. Cense, E. Consten, G. Creemers, R. Crolla, J. T. Dekker, J. Demelinne, M. V. van Det, Karin K. van Diepen, M. Diepeveen, E. V. van Duyn, E. D. van den Ende, Pauline Evers, A. V. van Geloven, Erwin van der Harst, J. Heemskerk, J. Heikens, D. A. Hess, B. Inberg, J. Jansen, F. Kloppenberg, Thomas J M Kootstra, R. Kortekaas, M. Los, E. Madsen, H. V. D. van der Mijle, L. Mol, P. Neijenhuis, S. Nienhuijs, Loes van den Nieuwenhof, K. C. Peeters, S. W. Polle, J. Pon, Pieter Poortman, S. Radema, Bert van Ramshorst, P. D. de Reuver, K. Rovers, R. F. Schmitz, N. Sluiter, D. Sommeijer, E. Sonneveld, T. V. van Sprundel, S. Veltkamp, M. Vermaas, V. Verwaal, E. Wassenaar, J. Wegdam, J. D. de Wilt, M. Westerterp, F. Wit, A. Witkamp, Karlijn van Woensdregt, E. S. van der Zaag, Mandy Zournas   +90 more
semanticscholar   +1 more source